Sara Baratchi

Dr. Sara Baratchi

School of Health and Biomedical Sciences, RMIT University, Bundoora Campus, Melbourne, Victoria 3083, Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
KKKhashayar Khoshmanesh
Khashayar Khoshmanesh
SNSaeid Nahavandi
Saeid Nahavandi
SBSara Baratchi
Sara Baratchi
AMArnan Mitchell
Arnan Mitchell
KKKourosh Kalantar-Zadeh
Kourosh Kalantar-Zadeh

1 July 2009 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
JKJagat Kanwar
Jagat Kanwar
RKRupinder K. Kanwar
Rupinder K. Kanwar
HBHannah Burrow
Hannah Burrow
SBSara Baratchi
Sara Baratchi
Nitric oxide (NO) is a short-life molecule produced by the enzyme known as the nitric oxide synthase (NOS), in a reaction that converts arginine and oxygen into citrulline and NO. There are three isoforms of the enzyme: neuronal NOS (nNOS, also called NOS1), inducible NOS (iNOS or NOS2), and endothelial NOS (eNOS or NOS3). It is now known that each of these isoforms may be expressed in a variety of tissues and cell types. This paper is a review of the current knowledge of various functions of NO in diseases. We discuss in more detail its role in Cancer, the role of NO in myocardial pathophysiology, in central nervous system (CNS) pathologies. Other diseases such as inflammation, asthma, in chronic liver diseases, inflammatory bowel disease (IBD), arthritis, are also discussed. This review also covers the role of NO in cardiovascular, central nervous, pancreas, lung, gut, kidney, myoskeletal and chronic liver diseases (CLD). The ubiquitous role that the simple gas nitric oxide plays in the body, from maintaining vascular homeostasis and fighting infections to acting as a neurotransmitter and its role in cancer, has spurred a lot of interest among researchers all over the world. Nitric oxide plays an important role in the physiologic modulation of coronary artery tone and myocardial function. Nitric oxide from iNOS appears to be a key mediator of such glial-induced neuronal death. The high sensitivity of neurons to NO is partly due to NO causing inhibition of respiration, rapid glutamate release from both astrocytes and neurons, and subsequent excitotoxic death of the neurons.

15 November 2021 in Biological Reviews
Verified
Journal Article
Closed access
PDF file
ALAustin Lai
Austin Lai
CCCharles Cox
Charles Cox
NSNadia Chandra Sekar
Nadia Chandra Sekar
PTPeter Thurgood
Peter Thurgood
AJAnthony Jaworowski
Anthony Jaworowski
SBSara Baratchi
Sara Baratchi

1 March 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
FKFarnaz Khoshmanesh
Farnaz Khoshmanesh
PTPeter Thurgood
Peter Thurgood
Elena PirogovaElena Pirogova
Elena Pirogova
SNSaeid Nahavandi
Saeid Nahavandi
SBSara Baratchi
Sara Baratchi

1 September 2017 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
SBSara Baratchi
Sara Baratchi
KKKhashayar Khoshmanesh
Khashayar Khoshmanesh
OWOwen L. Woodman
Owen L. Woodman
SPSimon Potocnik
Simon Potocnik
KPKarlheinz Peter
Karlheinz Peter
PMPeter McIntyre
Peter McIntyre

15 September 2020 in Circulation
Verified
Journal Article
Open access
PDF file
SBSara Baratchi
Sara Baratchi
MZMaria T.K. Zaldivia
Maria T.K. Zaldivia
MWMaria Wallert
Maria Wallert
JLJulia Loseff-Silver
Julia Loseff-Silver
SASefaa Al-Aryahi
Sefaa Al-Aryahi
KPKarlheinz Peter
Karlheinz Peter
Background: Aortic valve stenosis is an increasingly prevalent degenerative and inflammatory disease. Transcatheter aortic valve implantation (TAVI) has revolutionized its treatment, thereby avoiding its life-threatening/disabling consequences. Whether aortic valve stenosis is accelerated by inflammation and whether it is itself a cause of inflammation are unclear. We hypothesized that the large shear forces exerted on circulating cells, particularly on the largest circulating cells, monocytes, while passing through stenotic aortic valves result in proinflammatory effects that are resolved with TAVI. Methods: TAVI provides a unique opportunity to compare the activation status of monocytes under high shear stress (before TAVI) and under low shear stress (after TAVI). The activation status of monocytes was determined with a single-chain antibody, MAN-1, which is specific for the activated β 2 -integrin Mac-1. Monocyte function was further characterized by the adhesion of myocytes to stimulated endothelial cells, phagocytic activity, uptake of oxidized low-density lipoprotein, and cytokine expression. In addition, we designed a microfluidic system to recapitulate the shear rate conditions before and after TAVI. We used this tool in combination with functional assays, Ca 2+ imaging, siRNA gene silencing, and pharmacological agonists and antagonists to identify the key mechanoreceptor mediating the shear stress sensitivity of monocytes. Last, we stained for monocytes in explanted stenotic aortic human valves. Results: The resolution of high shear stress through TAVI reduces Mac-1 activation, cellular adhesion, phagocytosis, oxidized low-density lipoprotein uptake, and expression of inflammatory markers in monocytes and plasma. Using microfluidics and pharmacological and genetic studies, we could recapitulate high shear stress effects on isolated human monocytes under highly controlled conditions, showing that shear stress–dependent calcium influx and monocyte adhesion are mediated by the mechanosensitive ion channel Piezo-1. We also demonstrate that the expression of this receptor is shear stress dependent and downregulated in patients receiving TAVI. Last, we show monocyte accumulation at the aortic side of leaflets of explanted aortic valves. Conclusions: We demonstrate that high shear stress, as present in patients with aortic valve stenosis, activates multiple monocyte functions, and we identify Piezo-1 as the mainly responsible mechanoreceptor, representing a potentially druggable target. We demonstrate an anti-inflammatory effect and therefore a novel therapeutic benefit of TAVI.